Hubei Biocause Pharmaceutical Co (SZSE:000627) 3-Year EBITDA Growth Rate : 79.40% (As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Hubei Biocause Pharmaceutical Co 3-Year EBITDA Growth Rate?

Hubei Biocause Pharmaceutical Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.39.

During the past 12 months, Hubei Biocause Pharmaceutical Co's average EBITDA Per Share Growth Rate was -59.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 79.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 13.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Hubei Biocause Pharmaceutical Co was 232.20% per year. The lowest was -68.30% per year. And the median was 12.20% per year.

Competitive Comparison of Hubei Biocause Pharmaceutical Co's 3-Year EBITDA Growth Rate

For the Insurance - Life subindustry, Hubei Biocause Pharmaceutical Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hubei Biocause Pharmaceutical Co's 3-Year EBITDA Growth Rate Distribution in the Insurance Industry

For the Insurance industry and Financial Services sector, Hubei Biocause Pharmaceutical Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Hubei Biocause Pharmaceutical Co's 3-Year EBITDA Growth Rate falls into.

Hubei Biocause Pharmaceutical Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Hubei Biocause Pharmaceutical Co (SZSE:000627) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Hubei Biocause Pharmaceutical Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Hubei Biocause Pharmaceutical Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Hubei Biocause Pharmaceutical Co (SZSE:000627) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Insurance » Hubei Biocause Pharmaceutical Co Ltd (SZSE:000627) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

2nd Floor, Building 1, No. 1 Tianshan Road, Guohua Huijin Center, Zhanghe New District, Hubei Province, Jingmen, CHN, 448000

Website

http://www.tianmaogroup.net

Hubei Biocause Pharmaceutical Co Ltd is a China-based company engaged in life insurance, health insurance, accident insurance, and other life insurance businesses, medicine, and chemical businesses. The company generates its revenue in the form of premiums.

Hubei Biocause Pharmaceutical Co (SZSE:000627) Headlines

No Headlines